Zobrazeno 1 - 10
of 587
pro vyhledávání: '"G, Somlo"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
C. Ladbury, A. Rincon, J. Song, S. Armenian, A. Liu, R. Spielberger, L. Popplewell, F. Sahebi, P. Parker, S. Forman, D. Snyder, A. Dagis, P. Frankel, D. Yang, J. Wong, G. Somlo
Publikováno v:
Radiotherapy and Oncology. 170:S992-S993
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecc2dfb8290015b5c61fe933a1e77b31
https://doi.org/10.1016/s0167-8140(22)03135-8
https://doi.org/10.1016/s0167-8140(22)03135-8
Autor:
Enrique Soto-Perez-de-Celis, Joanne E. Mortimer, Arnold Rotter, Yuan Yuan, Daneng Li, Christina Yeon, Suzette Blanchard, Rachel Morrison, Vani Katheria, Nimit Sudan, Samuel Chung, J Waisman, Arti Hurria, Jennifer Choi, Ty Lee, Abrahm Levi, Thehang H. Luu, G. Somlo, Anne M. Noonan, Peggy Burhenn, Andrea Rubalcava, Anait Arsenyan
Publikováno v:
Clin Breast Cancer
Introduction Phase II clinical trials including geriatric assessment (GA) measures are critical for improving the evidence base for older adults with cancer. We assessed the efficacy and tolerability of nab-paclitaxel in older adults with metastatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::747cd26eaf608be14aea56e7fcbbb581
https://doi.org/10.1016/j.clbc.2018.10.002
https://doi.org/10.1016/j.clbc.2018.10.002
Publikováno v:
Cancer Research. 79:P6-21
Background No targeted therapies have been approved for triple negative breast cancer (TNBC) thus far. Retinoblastoma protein (pRb), a major substrate of cyclin-dependent kinase (CDK) 4/6, might be a potential target especially in chemoresistant TNBC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fa0eef19df271b66075a4bac7f89198
https://doi.org/10.1158/1538-7445.sabcs18-p6-21-08
https://doi.org/10.1158/1538-7445.sabcs18-p6-21-08
Publikováno v:
Cancer Research. 79:P3-06
Background. We recently described six distinct genomic configurations characterized by large numbers of distributed somatic tandem duplications (TDs) known as Tandem Duplicator Phenotypes (TDPs). Different TDPs feature TDs of different span sizes, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4240c60663050985d7546bbb725a413d
https://doi.org/10.1158/1538-7445.sabcs18-p3-06-09
https://doi.org/10.1158/1538-7445.sabcs18-p3-06-09
Autor:
Kemeberly Charles, Laura Kruper, D Mitani, Joanne E. Mortimer, Arti Hurria, C Uranga, I Paredero-Perez, Enrique Soto-Perez-de-Celis, Heeyoung Kim, Jessica Vazquez, Jeanine Moreno, Lesley Taylor, NH Patel, Vani Katheria, Elsa Roberts, G. Somlo, Yexian Yuan, Abrahm Levi, C-L Sun, J Waisman
Publikováno v:
Cancer Research. 79:P6-16
Background: Almost a quarter of older adults in the United States will identify themselves as Hispanic/Latino by 2060. Our group has previously developed and validated a self-administered geriatric assessment tool which can be used to identify functi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f099637df8d51c60cde8a5a719c3aad3
https://doi.org/10.1158/1538-7445.sabcs18-p6-16-04
https://doi.org/10.1158/1538-7445.sabcs18-p6-16-04
Autor:
T Luu, Aileen Tang, Joanne E. Mortimer, G. Somlo, Arti Hurria, N Tank Patel, J Waisman, Susan E. Yost, Yexian Yuan, Norma Martinez, M Li, Jana Portnow, Kim Robinson, H Yin, Lucille Leong, Suzette Blanchard
Publikováno v:
Cancer Research. 79:P6-18
Background: Alteration of PI3K/Akt/mTOR pathway is the most common genomic abnormality detected in triple negative breast cancer (TNBC). Everolimus acts synergistically with eribulin in inducing apoptosis in TNBC cell lines and xenografts in our prec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ac42291eb92d1a96d538d729139a3f4
https://doi.org/10.1158/1538-7445.sabcs18-p6-18-18
https://doi.org/10.1158/1538-7445.sabcs18-p6-18-18
Autor:
J Waisman, Joanne E. Mortimer, Arti Hurria, Daniel Schmolze, John H. Yim, T Treece, Y Yuan, Laura Kruper, Lusine Tumyan, M Li, Veronica Jones, Christina Yeon, Paul Frankel, G. Somlo
Publikováno v:
Cancer Research. 79:P1-15
Background: Response to neoadjuvant therapy (NT) predicts progression-free and overall survival in triple negative breast cancer (TNBC). Carboplatin has shown efficacy in patients with TNBC. The current phase II prospective neoadjuvant trial was desi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3c2519b4389c4c502fe624b5c1c3403
https://doi.org/10.1158/1538-7445.sabcs18-p1-15-07
https://doi.org/10.1158/1538-7445.sabcs18-p1-15-07
Autor:
J Waisman, Daniel Schmolze, Norma Martinez, Aileen Tang, G. Somlo, Susan E. Yost, Peter P. Lee, S Apple, B Mendez, Mina S. Sedrak, Joanne E. Mortimer, N Tank, Paul Frankel, Timothy W. Synold, Yate-Ching Yuan, Arti Hurria
Publikováno v:
Cancer Research. 78:OT1-05
Background: Androgen receptor (AR) targeted therapy and immunotherapy represent one of the most promising strategies for metastatic triple negative breast cancer (mTNBC), which accounts for 15-20% of all breast cancers. As a nonsteroidal selective an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6157decb941f54585a7ac1ad0c1cf485
https://doi.org/10.1158/1538-7445.sabcs17-ot1-05-02
https://doi.org/10.1158/1538-7445.sabcs17-ot1-05-02